Tomohiro Makino

489 citations
25 papers · 364 indexed · h-index 8
Topics
Pharmaceutical Economics and Policy (6 papers)Monoclonal and Polyclonal Antibodies Research (5 papers)CAR-T cell therapy research (3 papers)
Partner nations
JapanUnited StatesGreece

In The Last Decade

Tomohiro Makino

24 papers receiving 355 citations

Peers

Tomohiro Makino
Comparison fields: 5 of 87
  • Molecular Biology 231
  • Radiology, Nuclear Medicine and Imaging 73
  • Genetics 68
  • Ecology 47
  • Biotechnology 40
Replace Jim Kling with:
Jim Kling United States
Christian Hoffmeister Germany
О.Г. Леонова Russia
Arthur Klausner United States
Ina Theobald Germany
M.E. Nilsson Sweden
Mark Pogson United States
Michelle Burger Australia
Zhengfei Lu United States
Amanda Dugan United States
Tomohiro Makino relative to Jim Kling United States Jim Kling's profile →
Citations per field
00.5×3.6×
Jim Kling · 1×
Citations per year

Countries citing papers authored by Tomohiro Makino

Since Specialization
Citations

This map shows the geographic impact of Tomohiro Makino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiro Makino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiro Makino more than expected).

Fields of papers citing papers by Tomohiro Makino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohiro Makino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiro Makino. The network helps show where Tomohiro Makino may publish in the future.

Co-authorship network of co-authors of Tomohiro Makino

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiro Makino. A scholar is included among the top collaborators of Tomohiro Makino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiro Makino. Tomohiro Makino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 17
4 4
5 5
6 13
7 6
8 5
9 10
10 6
11 2
12 4
13 20
14 1
15 24
16 1
17 150
18 57
19 17
20
[Expressions of 2H4 and 4B4 antigens on ATL cells].
1

About Tomohiro Makino

Tomohiro Makino is a scholar working on Endocrine and Autonomic Systems, Management of Technology and Innovation and Economics and Econometrics, having authored 25 papers that have together received 364 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Biotechnology (40 citations), Molecular Biology (231 citations) and Radiology, Nuclear Medicine and Imaging (73 citations). Tomohiro Makino has collaborated with scholars based in Japan, United States and Greece. Frequent co-authors include George Georgiou, Γεώργιος Σκρέτας, Kota Kodama, Yeongjoo Lim, Shintaro Sengoku, Mark Pogson, Navin Varadarajan, Maki Terakawa, Ryuichi Nakamura and Kimiaki Utsugisawa. Their work appears in journals such as PLoS ONE, Scientific Reports and Methods in enzymology on CD-ROM/Methods in enzymology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026